mRNA |
Bexarotene |
CTRPv2 |
pan-cancer |
AAC |
-0.0072 |
0.8 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.007 |
0.8 |
mRNA |
EX-527 |
CTRPv2 |
pan-cancer |
AAC |
0.0076 |
0.8 |
mRNA |
VX-680 |
CTRPv2 |
pan-cancer |
AAC |
-0.02 |
0.8 |
mRNA |
JQ-1:vorinostat (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0065 |
0.8 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0063 |
0.8 |
mRNA |
HLI 373 |
CTRPv2 |
pan-cancer |
AAC |
-0.0068 |
0.8 |
mRNA |
BRD9876 |
CTRPv2 |
pan-cancer |
AAC |
-0.0072 |
0.9 |
mRNA |
GNF-2 |
GDSC1000 |
pan-cancer |
AAC |
-0.01 |
0.9 |
mRNA |
S-Trityl-L-cysteine |
FIMM |
pan-cancer |
AAC |
0.033 |
0.9 |